Concepedia
Statistics
Publications
3
Citations
265
H-Index
Active since
2011
Affiliations
Novartis (Switzerland)(Current)
Novartis Institutes for BioMedical Research
Emeline Evrot is an author at Novartis (Switzerland).
Publications per year
2011–2013
Genetic resistance to JAK2 enzymatic inhibitors is overcome by HSP90 inhibition
Oliver Weigert, Andrew A. Lane, Liat Bird et al. · The Journal of Experimental Medicine · 2012 · 161 citations · Full text
JAK1/2 and Pan-Deacetylase Inhibitor Combination Therapy Yields Improved Efficacy in Preclinical Mouse Models of JAK2V617F-Driven Disease
Emeline Evrot, Nicolas Ebel, Vincent Romanet et al. · Clinical Cancer Research · 2013 · 76 citations
Improved Efficacy Upon Combined JAK1/2 and Pan-Deacetylase Inhibition Using Ruxolitinib (INC424) and Panobinostat (LBH589) in Preclinical Mouse Models of JAK2V617F-Driven Disease
Fabienne Baffert, Emeline Evrot, Nicolas Ebel et al. · Blood · 2011 · 28 citations
1–3 of 3